At the February 2015 ACIP meeting held last month, recommendations were made for meningococcal, influenza, and HPV vaccines. The updated recommendations for meningococcal and HPV vaccines were particularly important, as they each come with unique challenges.
You may have missed the recent webinars hosted by NFID, discussing how to overcome these challenges, but archived versions of the webinars are available online at http://www.nfid.org/webinars:
The Role of New Serogroup B Vaccines in Preventing Meningitis Outbreaks: NFID experts, Carol J. Baker, MD, Lorry G. Rubin, MD, and William Schaffner, MD, discuss unique challenges of meningococcal disease, new ACIP recommendations for serogroup B vaccine use, and considerations for future recommendations.
Five Key Steps to Improve HPV Vaccination Rates in Your Practice: Joseph A. Bocchini, Jr., MD and Noel T. Brewer, PhD discuss HPV vaccination barriers and opportunities and will present five key steps that healthcare professionals (HCPs) can take to improve HPV vaccination rates in their practices, based on the NFID Call to Action, HPV Vaccination as a Public Health Priority.
written by: Amy Pisani, MS, Executive Director, Every Child By Two
The Advisory Committee on Immunization Practices (ACIP) conducted an abbreviated meeting on February 26, 2015 due to the threat of a winter storm in the Atlanta, Georgia region. The ACIP, which consists of 15 voting members who have expertise in vaccinology, immunology, healthcare and public health, makes recommendations to the Centers for Disease Control and Prevention (CDC) regarding vaccinations approved for use by the Food and Drug Administration (FDA). The recommendations pertain to the timing and intervals of vaccines which are included on the childhood, adolescent and adult immunization schedules. At this February meeting, the ACIP conducted three important votes which altered or created new recommendations for meningococcal vaccine, influenza vaccine and HPV vaccine.
Meningococcal Serogroup B Vaccine
Two new vaccines to protect against meningococcal serogroup B…
View original post 1,778 more words